Axel Haferkamp - Concepedia

Author

Axel Haferkamp

Also Known As

A Haferkamp, A. HAFERKAMP, A. Haferkamp, A. Haferkamp, AXEL HAFERKAMP, Alexander Buchner, Axel HAFERKAMP, Axel Haferkamp, C. Hampel, Chantada, Venancio

628

Publications

9.4K

Citations

H-Index

144

Concepts

All Affiliations

Goethe University Frankfurt Heidelberg University Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz University Hospital Frankfurt

About

Axel Haferkamp is an author at Goethe University Frankfurt specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	83	3.7K
2	Engineering	4	4	125
3	Health Sciences	4	4	127
4	Arts	2	2	109
5	Management	1	1	32

Axel Haferkamp

193

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension Juan Ignacio Martínez‐Salamanca, William C. Huang, Isabel Millán, European Urology Surgical OncologyUrologyPrognostic ImpactGenitourinary CancerMedicine	2010	270
Renal Cell Carcinoma With Tumor Thrombus Extension Into the Vena Cava: Prospective Long-Term Followup Axel Haferkamp, Patrick J. Bastian, Hildegard Jakobi, The Journal of Urology Inferior Vena CavaUrologySurgical OncologyVena CavaGenitourinary Cancer	2007	220
Lack of Ultrastructural Detrusor Changes Following Endoscopic Injection of Botulinum Toxin Type A in Overactive Neurogenic Bladder Axel Haferkamp, Brigitte Schurch, André Reitz, European Urology Urological ResearchUrologyVoiding DysfunctionUrogynecologyOveractive Neurogenic Bladder	2004	205
Preoperative Staging of Renal Cell Carcinoma With Inferior Vena Cava Thrombus Using Multidetector CT and MRI Peter Hallscheidt, Christian Fink, Axel Haferkamp, Journal of Computer Assisted Tomography	2005	160
Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? Jesco Pfitzenmaier, Sascha Pahernik, Tina Tremmel, British Journal of Urology	2008	152
Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma Julia Schleypen, Nicole Baur, Robert Kammerer, Clinical Cancer Research	2006	150
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma Nina Wagener, Stephan Macher‐Goeppinger, Maria Pritsch, BMC Cancer	2010	143
Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy Matthias May, Edwin Herrmann, Christian Bolenz, Annals of Surgical Oncology Urological ResearchUrologySurgical OncologyUrologic Cancer EpidemiologyGenitourinary Cancer	2011	133
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis Sascha D. Markowitsch, Patricia Schupp, Julia Lauckner, Cancers Chemoprevention StrategyRenal PathologyRenal InflammationCell CycleCancer Biology	2020	130
Molecular heterogeneity of TFE3 activation in renal cell carcinomas Stephan Macher‐Goeppinger, Wilfried Roth, Nina Wagener, Modern Pathology UrologyGenitourinary CancerKidney ResearchMedicineTumor Microenvironment	2011	119

Page 1